CINEVERSE CORP(NASDAQ:CNVS) stock Fundamental Analysis

Fundamental Rating

We assign a fundamental rating of 3 out of 10 to CNVS. CNVS was compared to 71 industry peers in the Entertainment industry. While CNVS seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, CNVS is valued expensive at the moment.

Quickly go to:

1. Profitability

1.1 Basic Checks

CNVS had negative earnings in the past year.

In the past year CNVS had a positive cash flow from operations.

In the past 5 years CNVS reported 4 times negative net income.

In multiple years CNVS reported negative operating cash flow during the last 5 years.

1.2 Ratios

CNVS's Return On Assets of -15.30% is on the low side compared to the rest of the industry. CNVS is outperformed by 77.27% of its industry peers.

With a Return On Equity value of -32.93%, CNVS is not doing good in the industry: 63.64% of the companies in the same industry are doing better.

CNVS's Return On Invested Capital of 11.32% is amongst the best of the industry. CNVS outperforms 84.85% of its industry peers.

		Industry Rank	Sector Rank
ROA	-15.3%
ROE	-32.93%
ROIC	11.32%

ROA(3y)-14.52%

ROA(5y)-28.21%

ROE(3y)-28.73%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

CNVS's Operating Margin of 8.04% is fine compared to the rest of the industry. CNVS outperforms 74.24% of its industry peers.

With a Gross Margin value of 53.40%, CNVS perfoms like the industry average, outperforming 57.58% of the companies in the same industry.

In the last couple of years the Gross Margin of CNVS has declined.

		Industry Rank	Sector Rank
OM	8.04%
PM (TTM)	N/A
GM	53.4%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y7.81%

GM growth 5Y-2.67%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

CNVS has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.

CNVS has more shares outstanding than it did 1 year ago.

Compared to 5 years ago, CNVS has more shares outstanding

Compared to 1 year ago, CNVS has a worse debt to assets ratio.

2.2 Solvency

CNVS has an Altman-Z score of -6.53. This is a bad value and indicates that CNVS is not financially healthy and even has some risk of bankruptcy.

Looking at the Altman-Z score, with a value of -6.53, CNVS is doing worse than 87.88% of the companies in the same industry.

The Debt to FCF ratio of CNVS is 1.79, which is an excellent value as it means it would take CNVS, only 1.79 years of fcf income to pay off all of its debts.

With a decent Debt to FCF ratio value of 1.79, CNVS is doing good in the industry, outperforming 78.79% of the companies in the same industry.

A Debt/Equity ratio of 0.10 indicates that CNVS is not too dependend on debt financing.

With a decent Debt to Equity ratio value of 0.10, CNVS is doing good in the industry, outperforming 68.18% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.1
Debt/FCF	1.79
Altman-Z	-6.53

ROIC/WACC1.29

WACC8.77%

2.3 Liquidity

A Current Ratio of 1.15 indicates that CNVS should not have too much problems paying its short term obligations.

The Current ratio of CNVS (1.15) is comparable to the rest of the industry.

A Quick Ratio of 1.15 indicates that CNVS should not have too much problems paying its short term obligations.

CNVS has a better Quick ratio (1.15) than 60.61% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.15
Quick Ratio	1.15

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 27.37% over the past year.

The Revenue has grown by 39.86% in the past year. This is a very strong growth!

Measured over the past years, CNVS shows a decrease in Revenue. The Revenue has been decreasing by -1.69% on average per year.

EPS 1Y (TTM)27.37%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%277%

Revenue 1Y (TTM)39.86%

Revenue growth 3Y16.09%

Revenue growth 5Y-1.69%

Sales Q2Q%206.87%

3.2 Future

The Earnings Per Share is expected to grow by 36.64% on average over the next years. This is a very strong growth

Based on estimates for the next years, CNVS will show a very strong growth in Revenue. The Revenue will grow by 21.97% on average per year.

EPS Next Y103.7%

EPS Next 2Y36.64%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year53%

Revenue Next 2Y21.97%

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

CNVS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Also next year CNVS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

83.33% of the companies in the same industry are more expensive than CNVS, based on the Enterprise Value to EBITDA ratio.

72.73% of the companies in the same industry are more expensive than CNVS, based on the Price/Free Cash Flow ratio.

		Industry Rank	Sector Rank
P/FCF	31.71
EV/EBITDA	6.46

4.3 Compensation for Growth

A more expensive valuation may be justified as CNVS's earnings are expected to grow with 36.64% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y36.64%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

CNVS does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

CINEVERSE CORP

NASDAQ:CNVS (2/21/2025, 8:10:27 PM)

After market: 4.1107 -0.18 (-4.18%)

4.29

-0.04 (-0.92%)

Chartmill FA Rating

GICS SectorCommunication Services

GICS IndustryGroupMedia & Entertainment

GICS IndustryEntertainment

Earnings (Last)02-12 2025-02-12/amc

Earnings (Next)06-30 2025-06-30/amc

Inst Owners15.47%

Inst Owner Change27.24%

Ins Owners12.7%

Ins Owner Change3.8%

Market Cap68.08M

Analysts82.5

Price Target8.67 (102.1%)

Short Float %3.14%

Short Ratio2.56

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)2

Avg Revenue beat(2)13.01%

Min Revenue beat(2)9.79%

Max Revenue beat(2)16.23%

Revenue beat(4)2

Avg Revenue beat(4)0.43%

Min Revenue beat(4)-15.94%

Max Revenue beat(4)16.23%

Revenue beat(8)2

Avg Revenue beat(8)-3.31%

Revenue beat(12)6

Avg Revenue beat(12)7.35%

Revenue beat(16)9

Avg Revenue beat(16)7.26%

PT rev (1m)13.33%

PT rev (3m)13.33%

EPS NQ rev (1m)-80%

EPS NQ rev (3m)67.86%

EPS NY rev (1m)-50%

EPS NY rev (3m)125%

Revenue NQ rev (1m)-6.46%

Revenue NQ rev (3m)3.01%

Revenue NY rev (1m)5.73%

Revenue NY rev (3m)21.36%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.94
P/FCF	31.71
P/OCF	18.51
P/B	1.82
P/tB	5.32
EV/EBITDA	6.46

EPS(TTM)-0.69

EYN/A

EPS(NY)-0.09

Fwd EYN/A

FCF(TTM)0.14

FCFY3.15%

OCF(TTM)0.23

OCFY5.4%

SpS4.57

BVpS2.36

TBVpS0.81

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-15.3%
ROE	-32.93%
ROCE	15.83%
ROIC	11.32%
ROICexc	13.31%
ROICexgc	46.31%
OM	8.04%
PM (TTM)	N/A
GM	53.4%
FCFM	2.96%

ROA(3y)-14.52%

ROA(5y)-28.21%

ROE(3y)-28.73%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y7.81%

GM growth 5Y-2.67%

F-Score6

Asset Turnover0.9

Health

		Industry Rank	Sector Rank
Debt/Equity	0.1
Debt/FCF	1.79
Debt/EBITDA	0.4
Cap/Depr	40.67%
Cap/Sales	2.11%
Interest Coverage	5.42
Cash Conversion	38.35%
Profit Quality	N/A
Current Ratio	1.15
Quick Ratio	1.15
Altman-Z	-6.53

F-Score6

WACC8.77%

ROIC/WACC1.29

Cap/Depr(3y)25.17%

Cap/Depr(5y)25.31%

Cap/Sales(3y)1.73%

Cap/Sales(5y)3.34%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)27.37%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%277%

EPS Next Y103.7%

EPS Next 2Y36.64%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)39.86%

Revenue growth 3Y16.09%

Revenue growth 5Y-1.69%

Sales Q2Q%206.87%

Revenue Next Year53%

Revenue Next 2Y21.97%

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y234.77%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year343.63%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y125.11%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y147.35%

OCF growth 3YN/A

OCF growth 5YN/A

CINEVERSE CORP (CNVS) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens